CRP and diabetes mellitus: Sitagliptin effect on diabetes-associated inflammation was assessed by measuring cardiac levels of IL-1β, TNF-α, and CRP, which were significantly elevated (p ≤ 0.001) in diabetic rats (Figure 6A–C).